HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The therapy of Adie's syndrome with dilute pilocarpine hydrochloride solutions.

Abstract
Impressed by the benefit two patients with Adie's Syndrome derived from topical 0.1% pilocarpine therapy, we performed the present study to examine the measurable effects of 0.1% pilocarpine in several patients with this syndrome. Our study suggests those patients with Adie's Syndrome who lack stereoacuity may benefit from long term therapy with dilute pilocarpine if their stereoacuity may benefit from long term therapy with dilute pilocarpine if their stereoacuity improves following a single drop of 0.1% pilocarpine. Therefore, we recommend measuring stereoacuity during pupil diagnostic testing with 0.1% pilocarpine hydrochloride. Potential problems concerning medical therapy of Adie's Syndrome with parasympathomimetics are discussed.
AuthorsA J Flach, B J Dolan
JournalJournal of ocular pharmacology (J Ocul Pharmacol) Vol. 1 Issue 4 Pg. 353-62 ( 1985) ISSN: 8756-3320 [Print] United States
PMID3880084 (Publication Type: Journal Article)
Chemical References
  • Ophthalmic Solutions
  • Pilocarpine
Topics
  • Adie Syndrome (drug therapy)
  • Dose-Response Relationship, Drug
  • Humans
  • Ophthalmic Solutions
  • Pilocarpine (administration & dosage)
  • Reflex, Pupillary (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: